Goldman Sachs Maintains Owens & Minor Rating And Price Target


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Owens & Minor, Inc. (NYSE: OMI) reported FY3Q10 EPS of $0.50, versus our/consensus estimates at $0.48/$0.49, Goldman Sachs reports. Revenue grew 1.4% year-over-year in the face of challenging utilization trends, which was relatively in line with Street expectations and 2.5% above Goldman Sachs' expectations.“While the quarter was slightly better than what we perceived to be low expectations, we still believe hospital utilization trends pose a significant headwind and are likely to persist beyond this year,” Goldman Sachs writes. “We maintain our Sell rating and $25 12-month price target.”Owens & Minor closed Monday at $27.94.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst RatingsGoldman SachsHealth CareHealth Care DistributorsOwens & Minor